It's All About Earnings, Hugh Johnson Says

It's All About Earnings, Hugh Johnson Says

Hugh Johnson, chairman and CIO of Hugh Johnson Advisors, talks about his three-year market forecast. Bloomberg Intelligence's Sam Fazeli discusses big pharma earning as Merck, Eli Lilly and Glaxo report this week. Liam Denning, a Bloomberg Gadfly columnist covering energy, talks about Halliburton earnings and gives an overview of the oil services sector. Finally, Jaimin Patel, a senior credit strategist at Bloomberg Intelligence, tells Pimm Fox and Lisa Abramowicz how a default may be looming for Venezuela.

See omnystudio.com/listener for privacy information.

Avsnitt(3351)

Big Mistake To Not Enlist Europe Against China: Rhodes (Podcast)

Big Mistake To Not Enlist Europe Against China: Rhodes (Podcast)

"Banker to the World" Bill Rhodes, President and CEO of William Rhodes Global Advisors, on the lack of a substantive China trade deal for the U.S. Jason Schenker, President of Prestige Economics and a...

1 Juli 201931min

GOP Strategist Heye Warns Dems Lurching Too Far Left

GOP Strategist Heye Warns Dems Lurching Too Far Left

Doug Heye, former RNC Communications Director and Republican Strategist, unpacks the second night of Democratic debates.  Maria Considine King, Senior Vice President, Practice Management at Commonweal...

28 Juni 201926min

Ford Moves In Right Direction With Euro Job Cuts: Kudla

Ford Moves In Right Direction With Euro Job Cuts: Kudla

David Kudla, CEO and Chief Investment Strategist at Mainstay Capital Management, on Ford eliminating 20% of its workforce across Europe. Chris Lu, Former Deputy Secretary of Labor and Senior Fellow at...

27 Juni 201927min

Little Upside Left in U.S. Junk Bonds: Diamond Hill

Little Upside Left in U.S. Junk Bonds: Diamond Hill

Bill Zox, CIO of Fixed income at Diamond Hill Capital Management, to discuss why there's little upside left in the high yield space. Leland Miller, CEO of China Beige Book International, on China Beig...

26 Juni 201928min

Allergan Is A Short-Term Cosmetic Fix For AbbVie: Nisen

Allergan Is A Short-Term Cosmetic Fix For AbbVie: Nisen

Max Nisen, Bloomberg Opinion health care columnist, on AbbVie buying Botox maker Allergan for $63 billion. CoinShares Chairman Danny Masters discusses the bitcoin rally and Facebook's new Libra crypto...

25 Juni 201925min

Private Equity Fees Are Ripe For The ’Vanguard Effect’

Private Equity Fees Are Ripe For The ’Vanguard Effect’

Eric Balchunas, Senior ETF Analyst for Bloomberg Intelligence, on Vanguard considering offering private equity to investors. Francis Greenburger, Time Equities Chairman & CEO, discusses how the recent...

24 Juni 201927min

Fed's Williams Is Trying to Clean Up Powell's Error (Podcast)

Fed's Williams Is Trying to Clean Up Powell's Error (Podcast)

Phil Orlando, Chief Equity Market Strategist at Federated Investors, on markets, the Fed and current investment strategy.  Clint Watts, Distinguished Research Fellow at the Foreign Policy Research Ins...

21 Juni 201929min

Slack CEO, CFO On Why They Went With A Direct Listing

Slack CEO, CFO On Why They Went With A Direct Listing

Mandeep Singh, Senior Tech Industry Analyst for Bloomberg Intelligence, on Slack going public in a direct listing, and Slack CEO Stewart Butterfield and CFO Allen Shim speak from the NYSE with Emily C...

20 Juni 201928min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
rss-borsens-finest
svd-tech-brief
uppgang-och-fall
rss-svart-marknad
avanzapodden
dynastin
borsmorgon
rss-dagen-med-di
rss-kort-lang-analyspodden-fran-di
24fragor
fill-or-kill
ekonomiekot-extra
lastbilspodden
rss-den-nya-ekonomin
tabberaset
rss-veckans-trade